Reslizumab in the management of poorly controlled asthma: the data so far

Interleukin-5, an important cytokine in the pathophysiology of asthma, participates in terminal maturation and increases chemotaxis, endothelial adhesion, and activation of eosinophils. Blockade of interleukin-5 activity with monoclonal antibodies have been successful in decreasing eosinophil counts...

Descripción completa

Detalles Bibliográficos
Autores principales: Maselli, Diego Jose, Velez, Maria Ines, Rogers, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012840/
https://www.ncbi.nlm.nih.gov/pubmed/27621657
http://dx.doi.org/10.2147/JAA.S94164